Somatic mutations in the mitochondria of rheumatoid arthritis synoviocytes
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
Somatic mutations have a role in the pathogenesis of a number of diseases, particularly cancers. Here we present data supporting a role of mitochondrial somatic mutations in an autoimmune disease, rheumatoid arthritis (RA). RA is a complex, multifactorial disease with a number of predisposition traits, including major histocompatibility complex (MHC) type and early bacterial infection in the joint. Somatic mutations in mitochondrial peptides displayed by MHCs may be recognized as non-self, furthering the destructive immune infiltration of the RA joint. Because many bacterial proteins have mitochondrial homologues, the immune system may be primed against these altered peptides if they mimic bacterial homologues. In addition, somatic mutations may be influencing cellular function, aiding in the acquirement of transformed properties of RA synoviocytes. To test the hypothesis that mutations in mitochondrial DNA (mtDNA) are associated with RA, we focused on the MT-ND1 gene for mitochondrially encoded NADH dehydrogenase 1 (subunit one of complex I – NADH dehydrogenase) of synoviocyte mitochondria from RA patients, using tissue from osteoarthritis (OA) patients for controls. We identified the mutational burden and amino acid changes in potential epitope regions in the two patient groups. RA synoviocyte mtDNA had about twice the number of mutations as the OA group. Furthermore, some of these changes had resulted in potential non-self MHC peptide epitopes. These results provide evidence for a new role for somatic mutations in mtDNA in RA and predict a role in other diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Some of the non-synonymous changes within MT-ND1 generated predicted epitopes for RA-predisposing MHC class II alleles (HLA-DRβ1*0101 and HLA-DRβ1*0401), suggesting a role for these mutations in RA pathogenesis44”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [44]
The cited source says what the claim attributes to it.
In the citing paper
“one study reported an increase in the frequency of mtDNA somatic mutations in synoviocytes from patients with RA compared with synoviocytes from patients with OA44”
From The role of mitochondria in rheumatic diseases (2022) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sequence and organization of the human mitochondrial genome
Anderson, S., Bankier, A. T., Barrell, B. G., de Bruijn, M. H. L., Coulson, A. R., Drouin, J., Eperon, I. C., Nierlich, D. P., Roe, B. A., Sanger, F., et al. (1981) · Nature · doi:10.1038/290457a0 · Cited by 9,636 · cited 2×
“Both forward and reverse primers in addition to the specific nucleotide sequence have a corresponding M13 tag (M13F, 5'-TGTAAAACGACGGCCAGT- 3' ; M13R, 5'-CAGGAAACAGCTATGACC-3'); start position numbering represents location of 5' end corresponding to the Anderson Reference Sequence [17].”
BackgroundMethodEvolving concepts of rheumatoid arthritis
Firestein, G. S. (2003) · Nature · doi:10.1038/nature01661 · Cited by 3,605 · cited 3×
“While these mutations are most likely a consequence of inflammation and not the cause of RA, they would be expected to affect disease progression [1].”
BackgroundInfluentialMitochondrial genome variation and the origin of modern humans
Ingman, M., Kaessmann, H., Pääbo, S., & Gyllensten, U. (2000) · Nature · doi:10.1038/35047064 · Cited by 1,551 · cited 1×
“The NCBI reference sequence (gi:17981852) also shows a deletion at this position when compared with the Anderson sequence (where there is a C) [20].”
BackgroundWolfe, F., & Michaud, K. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20311 · Cited by 644 · cited 1×
“A higher incidence of lymphoma is also well documented in RA, and somatic mutations may lead to enhancement of the aggressive nature of pathogenic cells [25].”
BackgroundMüller‐Ladner, U., Kriegsmann, J., Franklin, B. N., Matsumoto, S., Geiler, T., Gay, R. E., & Gay, S. (1996) · Europe PMC (PubMed Central) · Cited by 606
Pitkanen, S., & Robinson, B. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118798 · Cited by 388 · cited 1×
“Cells with complex I defects have also been shown to produce a higher amount of superoxide in vivo [8,13].”
BackgroundSomatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium
Firestein, G. S., Echeverri, F., Yeo, M., Zvaifler, N. J., & Green, D. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10895 · Cited by 377 · cited 2×
“Certain mutations within p53 then confer a survival advantage to the synoviocytes, giving them 'transformed' characteristics and participating in the perpetuation of disease [5].”
BackgroundLafyatis, R., Remmers, E. F., Roberts, A. B., Yocum, D. E., Sporn, M. B., & Wilder, R. L. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114011 · Cited by 323 · cited 1×
“RA synovial fibroblasts have many features of transformed cells – including the expression of oncogenes – and they have been shown to invade and destroy cartilage in the absence of T cells [2,3].”
BackgroundLoveland, B. (1990) · Cell · doi:10.1016/0092-8674(90)90345-f · Cited by 320 · cited 1×
“The maternally transmitted antigen of rats and mice is the product of a class I molecule that presents the maternal transplantation factor derived from the amino terminus of mtND1 [14].”
BackgroundIdentification of HLA-A2–restricted CD8+ Cytotoxic T Cell Responses in Primary Biliary Cirrhosis
Kita, H., Lian, Z.-X., Van de Water, J., He, X.-S., Matsumura, S., Kaplan, M., Luketic, V., Coppel, R. L., Ansari, A. A., & Gershwin, M. E. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20010956 · Cited by 292 · cited 1×
“There is growing evidence that somatic mutations within protein-coding genes of mtDNA may be recognized by the immune system: damaged mtDNA results in increased expression of MHC class I; and both MHC class I and class II can present mitochondrial peptides [11,12].”
Background
Cited by
Fibroblast‐like synoviocytes: key effector cells in rheumatoid arthritis
Bartok, B., & Firestein, G. S. (2010) · Immunological Reviews · doi:10.1111/j.0105-2896.2009.00859.x · Cited by 1,906
Synovial inflammation in osteoarthritis progression
Sanchez-Lopez, E., Coras, R., Torres, A., Lane, N. E., & Guma, M. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00749-9 · Cited by 1,041
Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes
Nygaard, G., & Firestein, G. S. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0413-5 · Cited by 928
Duality of fibroblast-like synoviocytes in RA: passive responders and imprinted aggressors
Bottini, N., & Firestein, G. S. (2013) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.190 · Cited by 907
Hypoxia, oxidative stress and inflammation
McGarry, T., Biniecka, M., Veale, D. J., & Fearon, U. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.03.042 · Cited by 601
Mitochondrial dysfunction and the inflammatory response
López-Armada, M. J., Riveiro-Naveira, R. R., Vaamonde-García, C., & Valcárcel-Ares, M. N. (2013) · Mitochondrion · doi:10.1016/j.mito.2013.01.003 · Cited by 530
“Furthermore, human RA synoviocytes (Da Sylva et al., 2005; Ospelt and Gay, 2005) and normal synoviocytes under arthritis-like conditions, such as hypoxia (Biniecka et al., 2011), which causes a significant increase in Δψm in synovial cells, have been shown to exhibit significantly higher mutation…”
BackgroundHypoxia, mitochondrial dysfunction and synovial invasiveness in rheumatoid arthritis
Fearon, U., Canavan, M., Biniecka, M., & Veale, D. J. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2016.69 · Cited by 439
DNA methylome signature in rheumatoid arthritis
Nakano, K., Whitaker, J. W., Boyle, D. L., Wang, W., & Firestein, G. S. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-201526 · Cited by 359
Apoptosis signaling pathways in osteoarthritis and possible protective role of melatonin
Hosseinzadeh, A., Kamrava, S. K., Joghataei, M. T., Darabi, R., Shakeri‐Zadeh, A., Shahriari, M., Reiter, R. J., Ghaznavi, H., & Mehrzadi, S. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12362 · Cited by 344
Review: Synovial Cell Metabolism and Chronic Inflammation in Rheumatoid Arthritis
Falconer, J., Murphy, A. N., Young, S. P., Clark, A. R., Tiziani, S., Guma, M., & Buckley, C. D. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40504 · Cited by 315
“Additional in vitro studies indicated an increased number of mtDNA mutations and ROS levels in RA FLS compared with OA FLS (63), correlating with elevated matrix metalloproteinase expression and an invasive phenotype in RA (61,64).”
BackgroundEtiology and Pathogenesis of Rheumatoid Arthritis
Firestein, G. S. (2017) · Kelley and Firestein's Textbook of Rheumatology · doi:10.1016/b978-0-323-31696-5.00069-3 · Cited by 278
Kim, E. K., Kwon, J.-E., Lee, S.-Y., Lee, E.-J., Kim, D. S., Moon, S.-J., Lee, J., Kwok, S.-K., Park, S.-H., & Cho, M.-L. (2017) · Cell Death & Disease · doi:10.1038/cddis.2016.490 · Cited by 209
“Mutations in mitochondrial genes are related to the pathogenesis and local inflammation involved in RA.(26,27) We hypothesized that another pathological mechanism of mitochondrial dysfunction in Th17 cells is involved in RA.”
BackgroundInfluentialCentral pathways causing fatigue in neuro-inflammatory and autoimmune illnesses
Morris, G., Berk, M., Walder, K., & Maes, M. (2015) · BMC Medicine · doi:10.1186/s12916-014-0259-2 · Cited by 181
“There is evidence of somatic mutations in the mitochondrial DNA (mtDNA) within synoviocytes of rheumatoid arthritis patients which may confer immunogenicity on mtDNA derived proteins which consequently adopt the character of DAMPS and be one of such entities thought to play a major role in the etiopathogenesis of this…”
BackgroundRegulation of DNA Methylation in Rheumatoid Arthritis Synoviocytes
Nakano, K., Boyle, D. L., & Firestein, G. S. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202572 · Cited by 164
The Role of Reactive Oxygen Species in the Rheumatoid Arthritis-Associated Synovial Microenvironment
Wang, X., Fan, D., Cao, X., Ye, Q., Wang, Q., Zhang, M., & Xiao, C. (2022) · Antioxidants · doi:10.3390/antiox11061153 · Cited by 189
Ishibashi, T. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990507 · Cited by 159
“Somatic mutations of mtDNA have been reported to be associated with RA [63].”
Rheumatoid Arthritis, Immunosenescence and the Hallmarks of Aging
Chalan, P., van den Berg, A., Kroesen, B., Brouwer, L., & Boots, A. M. H. (2015) · Current Aging Science · doi:10.2174/1874609808666150727110744 · Cited by 135
“The increase of mtDNA mutations were found only when compared to osteoarthritis (OA) control tissue [177], but not when compared to psoriatic arthritis (PsA) tissue [178].”
BackgroundHypoxia induces mitochondrial mutagenesis and dysfunction in inflammatory arthritis
Biniecka, M., Fox, E., Gao, W., Ng, C. T., Veale, D. J., Fearon, U., & O'Sullivan, J. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30395 · Cited by 109
The Future of Osteoarthritis Therapeutics: Targeted Pharmacological Therapy
Mobasheri, A. (2013) · Current Rheumatology Reports · doi:10.1007/s11926-013-0364-9 · Cited by 130
“Somatic mutations of mitochondrial DNA (mtDNA) have been described in synoviocytes from RA joints [61].”
BackgroundMitochondrial Dysfunction and Oxidative Stress in Rheumatoid Arthritis
López-Armada, M. J., Fernández-Rodríguez, J. A., & Blanco, F. J. (2022) · Antioxidants · doi:10.3390/antiox11061151 · Cited by 126
Coutant, F., & Miossec, P. (2019) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000664 · Cited by 109
Mitochondria as Key Players in the Pathogenesis and Treatment of Rheumatoid Arthritis
Clayton, S. A., MacDonald, L., Kurowska‐Stolarska, M., & Clark, A. R. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.673916 · Cited by 103
The role of mitochondria in rheumatic diseases
Becker, Y. L. C., Duvvuri, B., Fortin, P. R., Lood, C., & Boilard, E. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00834-z · Cited by 81
Valcarcel‐Ares, M. N., Riveiro-Naveira, R. R., Vaamonde‐García, C., Loureiro, J., Hermida-Carballo, L., Blanco, F. J., & López-Armada, M. J. (2014) · Rheumatology · doi:10.1093/rheumatology/keu016 · Cited by 86
Metabolic Checkpoints in Rheumatoid Arthritis
Pucino, V., Certo, M., Varricchi, G., Marone, G., Ursini, F., Rossi, F. W., de Paulis, A., Mauro, C., Raza, K., & Buckley, C. D. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00347 · Cited by 90
“Mitochondrial DNA (mtDNA) mutations and ROS production were found to be higher in RA compared to OA FLS (Da Sylva et al., 2005).”
BackgroundBiniecka, M., Kennedy, A., Ng, C. T., Chang, T. C., Balogh, E., Fox, E., Veale, D. J., Fearon, U., & O'Sullivan, J. N. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3424 · Cited by 65
“Higher incidence of mtDNA somatic mutations has also been detected in synoviocytes and synovial tissue of RA than OA controls [48]; however, the frequency of mitochondrial mutations has not been examined.”
BackgroundEffect of nitric oxide on mitochondrial activity of human synovial cells
Cillero‐Pastor, B., Martín, M. A., Arenas, J., López-Armada, M. J., & Blanco, F. J. (2011) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-12-42 · Cited by 56
“There are no previous studies of mitochondrial integrity in relation to the energy production in synoviocytes, although some mtDNA somatic mutations and the importance of normal Δψm have been studied [29,19].”
BackgroundGautam, S., Kumar, U., Kumar, M., Rana, D., & Dada, R. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.03.004 · Cited by 60
Etiology and Pathogenesis of Rheumatoid Arthritis
Firestein, G. S. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3285-4.10065-8 · Cited by 78
Role of mitochondrial dysfunction on rheumatic diseases
Vaamonde‐García, C., & López-Armada, M. J. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.008 · Cited by 45
de Jong, T. A., Semmelink, J. F., Denis, S. W., van de Sande, M. G. H., Houtkooper, R. H., & van Baarsen, L. G. M. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102974 · Cited by 47
Mitochondrial depolarisation and oxidative stress in rheumatoid arthritis patients
Moodley, D., Mody, G. M., Patel, N., & Chuturgoon, A. A. (2008) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2008.08.072 · Cited by 41
Al‐Azab, M., Qaed, E., Ouyang, X., Elkhider, A., Walana, W., Li, H., Li, W., Tang, Y., Adlat, S., Wei, J., et al. (2020) · FEBS Journal · doi:10.1111/febs.15181 · Cited by 42
Potential role of mitochondria in synoviocytes
Li, M., Luo, X., Long, X., Jiang, P., Jiang, Q. L., Guo, H., & Chen, Z. (2020) · Clinical Rheumatology · doi:10.1007/s10067-020-05263-5 · Cited by 34
“Studies indicate that some mitochondrial mutation of synoviocytes has resulted in potential non-self MHC peptide epitopes, which may be recognized by the immune system [23, 35].”
BackgroundResultRole of Mitochondrial Mutations in Cancer
Baysal, B. E. (2006) · Endocrine Pathology · doi:10.1385/ep:17:3:203 · Cited by 41
“Furthermore, the occurrence of somatic mtDNA mutations in neurodegenerative diseases, cardiac disorders, and aging [2], and even in the synoviocytes of patients with rheumatoid arthritis [ 29 ], precludes suggesting a straightforward association between the somatic mtDNA alterations and cancer.”
BackgroundThe mitochondrial inhibitor oligomycin induces an inflammatory response in the rat knee joint
Vaamonde‐García, C., Loureiro, J., Valcarcel‐Ares, M. N., Riveiro-Naveira, R. R., Ramil‐Gómez, O., Hermida-Carballo, L., Centeno, A., Meijide-Faílde, R., Blanco, F. J., & López-Armada, M. J. (2017) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-017-1621-2 · Cited by 30
“and infiltration of CD68+ and CD3+ cells [11, 12, 50].”
BackgroundSvendsen, A. J., Tan, Q., Jakobsen, M. A., Thyagarajan, B., Nygaard, M., Christiansen, L., & Mengel‐From, J. (2018) · Journal of Autoimmunity · doi:10.1016/j.jaut.2018.09.008 · Cited by 29
Huang, L., Hu, S., Shao, M., Wu, X., Zhang, J., & Cao, G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.639009 · Cited by 33
“Mutations in mitochondrial DNA have also been identified as a pathological sign of RA (Da Sylva et al., 2005).”
BackgroundMitochondrial bioenergetics and disease in Caenorhabditis elegans
Rabbitts, B. M., Sedensky, M. M., & Morgan, P. G. (2015) · Frontiers in bioscience · doi:10.2741/4305 · Cited by 26
“autoimmune diseases such as multiple sclerosis and rheumatoid arthritis (19-28).”
BackgroundChen, L., Duvvuri, B., Grigull, J., Jamnik, R., Wither, J., & Wu, G. E. (2014) · Human Immunology · doi:10.1016/j.humimm.2014.06.012 · Cited by 21
“Previous studies of rheumatoid arthritis reported a higher burden of somatic mutations in mtDNA in autoimmune individuals than in osteoarthritis controls [22].”
BackgroundSelf-citationAge-related mechanisms in the context of rheumatic disease
Alsaleh, G., Richter, F. C., & Simon, A. K. (2022) · Nature Reviews Rheumatology · doi:10.1038/s41584-022-00863-8 · Cited by 22
Silva, A. C. B. S., Botton, T., Rossi, A., Dobner, J., Bzioueche, H., Nguyen, T. N., Blot, L., Pagnotta, S., Kleszczyński, K., Steinbrink, K., et al. (2024) · Clinical and Translational Medicine · doi:10.1002/ctm2.1810 · Cited by 20
“6 Interestingly, MELAS (mitochondrial encephalopathy, lactic acidosis and stroke-like episodes) syndrome is principally due to a mutation in mtDNA and it is associated with a 10-fold increased risk of developing vitiligo compared to the general population.”
BackgroundSomatic mutations in mitochondria: the chicken or the egg?
Ospelt, C., & Gay, S. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1809 · Cited by 18
“In a recent article in Arthritis Research & Therapy, this group analyzed the presence of mitochondrial DNA (mtDNA) mutations in patients with RA and their possible role in the pathogenesis of RA [1].”
BackgroundLee, S. Y., Park, S.-H., Lee, S. W., Lee, S. H., Son, M. K., Choi, Y. H., Chung, W. T., & Yoo, Y. H. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0365-x · Cited by 17
Du, J., Yu, S., Wang, D., Chen, S., Chen, S., Zheng, Y., Wang, N., Chen, S., Li, J., & Shen, B. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa063 · Cited by 17
The Effect of Smoking on Mitochondrial Biogenesis in Patients With Graves Ophthalmopathy
Yüksel, N., Yaman, D., Paşaoğlu, Ö. T., & Paşaoğlu, H. (2019) · Ophthalmic Plastic and Reconstructive Surgery · doi:10.1097/iop.0000000000001514 · Cited by 14
“Somatic mtDNA mutations were found higher in the synovia of the patients with rheumatoid arthritis compared to patients with osteoartritis.(27) Affected mitochondrial biogenesis was shown in systemic lupus erythematosus which is an another autoimmune disease.”
ResultBlagov, A. V., Grechko, A. V., Nikiforov, N. G., Zhuravlev, A. D., Sadykhov, N. K., & Orekhov, A. N. (2022) · Metabolites · doi:10.3390/metabo12070634 · Cited by 16
Mitochondria: a breakthrough in combating rheumatoid arthritis
Li, S., Huo, C., Liu, A., & Zhu, Y. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1439182 · Cited by 15
Differential mitochondrial genome in patients with Rheumatoid Arthritis
Jaiswal, K. S., Khanna, S., Ghosh, A., Padhan, P., Raghav, S. K., & Gupta, B. (2021) · Autoimmunity · doi:10.1080/08916934.2020.1846182 · Cited by 12
Malik, S., Chakraborty, D., Agnihotri, P., Sharma, A., & Biswas, S. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101854 · Cited by 13
Jávor, P., Mácsai, A., Butt, E., Baráth, B., Jász, D. K., Horváth, T., Baráth, B., Csonka, Á., Török, L., Varga, E., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147553 · Cited by 14
The Human Immune System Recognizes Neopeptides Derived from Mitochondrial DNA Deletions
Duvvuri, B., Duvvuri, V. R. S. K., Wang, C., Chen, L., Wagar, L. E., Jamnik, V., Wu, J., Yeung, R. S. M., Grigull, J., Watts, T. H., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300774 · Cited by 13
“The significantly higher mtDNA mutation load in rheumatoid arthritis patients compared with osteoarthritis patients is among the mounting evidence that neopeptides generated from mutated mtDNA have a role in autoimmune disease (17).”
BackgroundSelf-citationImmunometabolism Dysfunction in the Pathophysiology and Treatment of Rheumatoid Arthritis
Masoumi, M., Hashemi, N., Moadab, F., Didehdar, M., Farahani, R., Khorramdelazad, H., Sahebkar, A., Johnston, T. P., & Karami, J. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666220907151213 · Cited by 12
Hirano, T., Fukushima, H., Sasaki, Y., Yoshikawa, N., Yoshida, M., & Oka, K. (2006) · International Immunopharmacology · doi:10.1016/j.intimp.2006.01.001 · Cited by 9
Iaconis, A., Molinari, F., Fusco, R., & Paola, R. D. (2025) · Biomedicines · doi:10.3390/biomedicines13071708 · Cited by 10
Lee, A. R., Woo, J. S., Lee, S.-Y., Shin, Y., Jeon, S. B., Jo, Y., Choi, H., Park, S., Kang, T., & Cho, M. (2026) · Autophagy · doi:10.1080/15548627.2026.2619283 · Cited by 10
“Consequently, ROS-induced mtDNA mutations promote synovial cell proliferation [16].”
Emerging perspectives in proteostasis: bridging mechanisms and therapeutics for human diseases
Borlepawar, A., Neu, M., Ma, Z., Deshpande, A., Bühringer, H., Hajieva, P., Frey, N., & Rangrez, A. Y. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02714-4 · Cited by 10
Nanotoxicity, Cytotoxicity, and Genotoxicity Mechanisms of Nanomaterials
Madkour, L. H. (2020) · Nanomedicine and nanotoxicology · doi:10.1007/978-3-030-37297-2_2 · Cited by 3
Wang, A., Ma, T., Yu, J., Hu, Y., & Di, X. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116622 · Cited by 3
Firestein, G. S. (2009) · Arthritis & Rheumatism · doi:10.1002/art.27187 · Cited by 2
Huang, F., Sun, K., Diao, L., Lu, K., Fan, Y., & Xie, G. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1928003 · Cited by 2
“Somatic mtDNA mutations have additionally been identi fi ed in rheumatoid synoviocytes, consistent with cumulative oxidative injury within a chronically hypoxic and metabolically stressed joint microenvironment (253).”
Nitric Oxide and the Respiratory Chain in Synovial Cells and Chondrocytes
López-Armada, M. J., Valcarcel‐Ares, M. N., Riveiro-Naveira, R. R., & Vaamonde‐García, C. (2012) · Springer eBooks · doi:10.1007/978-1-4614-6166-1_3 · Cited by 1
Reaction-diffusion processes in muscle metabolism --- Parametric and sensitivity analysis
Dasika, S. K. (2010) · Cited by 1
Application aspects of animal and human genomics
Ślaska, B., Makarewic, A., Surdyka, M., & Nisztuk, S. (2014) · Acta Scientiarum Polonorum. Zootechnica · Cited by 3
Forschungsstrategien zur ganzheitlichen Charakterisierung der Rheumatoiden Arthritis—
Thiel, A., & Thiesen, H.-J. (2005) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-005-0770-0 · Cited by 2
“Auch die Hinzuziehung von Sequenzdaten zur Überprüfung auf das Vorliegen von Mutationen [28] und von Genomdaten zur Prüfung von Genominstablilitäten [29] bzw.”
BackgroundBiochemical, apoptotic and cellular stress studies in rheumatoid arthritis.
Moodley, D. (2009) · ResearchSpace (University of KwaZulu-Natal)
Chapter 11 Rheumatoid Arthritis
Rovenský, J., & Pavelká, K. (2008)
Lee, S. Y., Bae, J. H., Lee, S. W., & Chung, W. T. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-eular.781
Inmunosenescencia y autoinmunidad: mecanismos e implicaciones patológicas
Ibarra, A. S. P., Criado-Villamizar, J., Niebles-Navas, M., Rojas-Castro, G., Monsalve, D. M., Acosta‐Ampudia, Y., & Ramírez-Santana, C. (2024) · Medicina · doi:10.56050/01205498.2336 · Cited by 1
Li, W., Yao, S., Wang, J., Yang, Y., Wang, T., Hai, M., Zhang, W., Wang, N., & Wan, Q. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48010111 · Cited by 1
“Additionally, studies have shown that patients with RA exhibit a higher frequency of mitochondrial mutations in synoviocytes and synovial tissues compared to those with osteoarthritis [22,23].”
Metadata
- Authors
- Da Sylva, T. R., Connor, A., Mburu, Y., Keystone, E., & Wu, G. E.
- Affiliations
- University Health Network (CA)
- York University (CA)
- Mount Sinai Hospital (CA)
- ORCID
- Keystone, Edward
- Venue
- Arthritis Research & Therapy
- Published
- 2005-04-28
- Volume
- 7
- Issue
- 4
- Pages
- R844-51
- ISSN
- 1478-6354 (ISSN-L)
- PMC
- PMC1175034
- OpenAlex
- W1598861942
- Cited by
- 73
- References
- 29
- Citations by year
- 2026: 5 · 2025: 1 · 2024: 4 · 2022: 9 · 2021: 3 · 2020: 7 · 2019: 3 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 3 · 2014: 5 · 2013: 4 · 2012: 4
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/2.0/ (tdm)
- creativecommons.org/licenses/by/2.0/ (vor)
- Locations
- Arthritis Research & Therapy (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- TSpace (University of Toronto) (submittedVersion)
- Funders
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Complementary and alternative medicine › Natural Compounds in Disease Treatment
- Keywords
- rheumatoid arthritis, mitochondrial DNA, synoviocytes, MT-ND1, NADH dehydrogenase complex I, autoimmunity, bacterial infection, osteoarthritis, mutational burden, autoimmune disease pathogenesis
- MeSH terms
- Arthritis, Rheumatoid, Cells, Cultured, DNA, Mitochondrial, Humans, Mitochondria, Mutation, Synovial Membrane
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.